# Fertility-sparing Therapy for Patients With Stage IA Endometrial Cancer

> **NCT05945407** · NA · RECRUITING · sponsor: **Peking University People's Hospital** · enrollment: 57 (estimated)

## Conditions studied

- Endometrial Neoplasms
- Endometrial Neoplasm Malignant
- Endometrial Neoplasm Malignant Stage I
- Carcinoma, Endometrioid
- Fertility Preservation

## Interventions

- **COMBINATION_PRODUCT:** Indication-extended Fertility-sparing Therapy

## Key facts

- **NCT ID:** NCT05945407
- **Lead sponsor:** Peking University People's Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2016-08-01
- **Primary completion:** 2023-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 57 (ESTIMATED)
- **Last updated:** 2023-07-14

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05945407

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05945407, "Fertility-sparing Therapy for Patients With Stage IA Endometrial Cancer". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05945407. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*